Description
An inhibitor of mTORC1 and mTORC2 formation; inhibits VEGF-driven and bFGF-driven endothelial cell proliferation (IC50s = 20 and 30 nM, respectively); reduces VEGF-A-driven phosphorylation of AktS473, an mTORC2 substrate; inhibits retinal neovascularization in mice with oxygen-induced retinopathy, Ad-VEGF-A-driven angiogenesis, and phosphorylation of AktS473 in vivo; has anticancer effects in glioma cancer cells and xenografts via AktS473 signaling downtstream of mTORC,
Formal name: 8-(1-hydroxyethyl)-2-methoxy-3-[(4-methoxyphenyl)methoxy]-6H-dibenzo[b,d]pyran-6-one
Synonyms: P529|RES-529|SG 00529
Molecular weight: 406.4
CAS: 914913-88-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Kinase Inhibitors|mTOR||Product Type|Biochemicals|Small Molecule Inhibitors|Kinases||Research Area|Cancer|Angiogenesis||Research Area|Cancer|Cell Signaling|Growth Factor Receptor Signaling||Research Area|Cancer|Cell Signaling|PI3K/Akt/mTOR Signaling||Research Area|Cell Biology|Cell Signaling|PI3K/Akt/mTOR Signaling